# Deep Phenotyping for Clinical Inferring Response in Treatment Resistant Depression

> **NCT06396312** · — · RECRUITING · sponsor: **Max-Planck-Institute of Psychiatry** · enrollment: 130 (estimated)

## Conditions studied

- Depressive; Disorder, Major, Single Episode, Major, With Psychotic Symptoms
- Depressive; Disorder, Major, Single Episode, Major (Without Psychotic Symptoms)
- Depressive Disorder, Major, Recurrent, With Psychotic Symptoms
- Depressive Disorder, Major, Recurrent, Without Psychotic Symptoms
- Depressive Disorder, Treatment-Resistant, Class I or II
- Depressive Disorder, Major, Moderate
- Depressive Disorder, Major, Severe

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06396312
- **Lead sponsor:** Max-Planck-Institute of Psychiatry
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-02
- **Primary completion:** 2028-04-01
- **Final completion:** 2029-04-01
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2025-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06396312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06396312, "Deep Phenotyping for Clinical Inferring Response in Treatment Resistant Depression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06396312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*